RESEARCH-USE BIOSIMILAR ANTIBODY

Guselkumab

Monoclonal antibody · IgG1

IL23AIgG1RUO

Guselkumab is a recombinant human IgG1 monoclonal antibody against the IL-23p19 subunit. Guselkumab binds to human and cynomolgus monkey IL-23 with Kd values of 3.3 and 1.9 pmol/L, respectively. Guselkumab inhibits production of cytokines lying downstream of the IL-23 signaling pathway and can be used for psoriatic arthritis research.

TARGETIL23A
YMonoclonal antibody
CATALOGSC-BS-493
CATALOG NUMBERSC-BS-493
MOLECULAR WEIGHTApprox. 144.8 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Guselkumab is a recombinant human IgG1 monoclonal antibody against the IL-23p19 subunit. Guselkumab binds to human and cynomolgus monkey IL-23 with Kd values of 3.3 and 1.9 pmol/L, respectively. Guselkumab inhibits production of cytokines lying downstream of the IL-23 signaling pathway and can be used for psoriatic arthritis research.

Guselkumab is a recombinant research-use antibody directed against IL23A.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Guselkumab | StellaCyte